News Orders & Deals Unicorn Fund Acquires 6.6022% Stake in Accretion Nutraveda Limited, Crosses Regulatory ThresholdUnicorn Fund Acquires 6.6022% Stake in Accretion Nutraveda Limited, Crosses Regulatory Threshold
Unicorn Fund has acquired 478000 equity shares in Accretion Nutraveda Limited, representing 6.6022% of the company's paid-up equity capital and crossing the 5% regulatory disclosure threshold. The acquisition was completed through IPO participation (471000 shares) and secondary market purchases (7000 shares) between February 4-5, 2026. This marks the fund's initial investment in the nutrition company, with the transaction authorized by Mr. Viren S Patel as Designated Partner.
*this image is generated using AI for illustrative purposes only.
Accretion Nutraveda Limited has announced that Unicorn Fund has acquired a significant stake in the company, crossing the regulatory disclosure threshold of 5%. The acquisition represents a notable investment by the fund in the nutrition and wellness sector company.
Acquisition Details
Unicorn Fund acquired 478000 equity shares of Accretion Nutraveda Limited, representing 6.6022% of the company's total paid-up equity share capital. This acquisition marks the fund's entry into the company as a substantial shareholder, having held no previous stake in the organization.
| Parameter | Details |
|---|---|
| Shares Acquired | 478000 |
| Percentage Stake | 6.6022% |
| Previous Holding | NIL |
| Acquirer Category | Non-Promoter |
Transaction Structure and Timeline
The acquisition was executed through multiple channels over two days in February 2026. The fund participated in the company's Initial Public Offering (IPO) while also making strategic purchases from the secondary market.
Acquisition Breakdown:
- IPO Participation: 471000 shares
- Anchor allocation: 466000 shares on February 4, 2026
- QIB Ex Anchor: 5000 shares on February 4, 2026
- Secondary Market Purchases: 7000 shares
- February 4, 2026: 1000 shares
- February 5, 2026: 6000 shares
Regulatory Compliance
The disclosure was made pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Under these regulations, any acquisition that results in holding 5% or more of a company's equity shares requires mandatory disclosure to stock exchanges.
| Regulatory Aspect | Details |
|---|---|
| Threshold Crossed | 5% |
| Final Holding | 6.6022% |
| Regulation | SEBI SAST Regulation 29(1) |
| Stock Exchange | BSE Limited |
Fund Authorization
The acquisition was authorized by Mr. Viren S Patel, serving as Designated Partner and Investment Manager for Unicorn Fund. The formal disclosure documentation was completed and submitted to BSE Limited on February 5, 2026, ensuring compliance with regulatory timelines.
Accretion Nutraveda Limited, formerly known as Accretion Nutraveda Private Limited, operates in the nutrition and wellness sector. The company's shares are listed on BSE Limited under scrip code 544694. This acquisition represents Unicorn Fund's confidence in the company's growth prospects and market position within the nutraceutical industry.
20
